Literature DB >> 2093441

Methotrexate--the rapidly acting drug.

N Songsiridej, D E Furst.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2093441     DOI： 10.1016/s0950-3579(05)80008-1

Source DB:  PubMed          Journal:  Baillieres Clin Rheumatol        ISSN： 0950-3579


× No keyword cloud information.
  11 in total

Review 1.  Clinical pharmacokinetics of low-dose pulse methotrexate in rheumatoid arthritis.

Authors:  B Bannwarth; F Péhourcq; T Schaeverbeke; J Dehais
Journal:  Clin Pharmacokinet       Date:  1996-03       Impact factor: 6.447

2.  Intra-articular methotrexate in the treatment of rheumatoid arthritis and psoriatic arthritis: a clinical and sonographic study.

Authors:  Annamaria Iagnocco; Angela Cerioni; Giulio Coari; Alejandra Ossandon; Raffaele Masciangelo; Guido Valesini
Journal:  Clin Rheumatol       Date:  2005-06-10       Impact factor: 2.980

3.  Prospidine versus methotrexate pulse in highly active rheumatoid arthritis: a controlled 6-month clinical trial.

Authors:  E V Benenson; O B Timina
Journal:  Clin Rheumatol       Date:  1994-03       Impact factor: 2.980

Review 4.  Pharmacokinetics and pharmacodynamics of methotrexate in non-neoplastic diseases.

Authors:  Jirí Grim; Jaroslav Chládek; Jirina Martínková
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

5.  Pharmacokinetics and pharmacodynamics of low-dose methotrexate in the treatment of psoriasis.

Authors:  Jaroslav Chládek; Jiøí Grim; Jiøina Martínková; Marie Simková; Jaroslava Vanìèková; Vìra Koudelková; Marie Noièková
Journal:  Br J Clin Pharmacol       Date:  2002-08       Impact factor: 4.335

6.  Conversion of endogenous arachidonic acid to 5,15-diHETE and lipoxins by polymorphonuclear cells from patients with rheumatoid arthritis.

Authors:  E Thomas; J L Leroux; F Blotman; C Chavis
Journal:  Inflamm Res       Date:  1995-03       Impact factor: 4.575

Review 7.  Clinical pharmacology and modification of autoimmunity and inflammation in rheumatoid disease.

Authors:  R Luqmani; C Gordon; P Bacon
Journal:  Drugs       Date:  1994-02       Impact factor: 9.546

Review 8.  Methotrexate in rheumatoid arthritis. An update.

Authors:  B Bannwarth; L Labat; Y Moride; T Schaeverbeke
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546

9.  Methotrexate for the treatment of thyroid eye disease.

Authors:  Diego Strianese; Adriana Iuliano; Mariantonia Ferrara; Chiara Comune; Immacolata Baronissi; Pasquale Napolitano; Alessia D'Alessandro; Piergiacomo Grassi; Giulio Bonavolontà; Paola Bonavolontà; Antonio Sinisi; Fausto Tranfa
Journal:  J Ophthalmol       Date:  2014-01-08       Impact factor: 1.909

10.  Methotrexate Decreases Tenofovir Exposure in Antiretroviral-Suppressed Individuals Living With HIV.

Authors:  David Gingrich; Amelia N Deitchman; Amy Kantor; Liusheng Huang; James H Stein; Judith S Currier; Priscilla Y Hsue; Heather J Ribaudo; Francesca T Aweeka
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-15       Impact factor: 3.771
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.